Scholarship will fund a 3-year PhD candidature to work in the Cancer, Ageing & Vaccine Laboratory (SHBS). Project is a collaboration with WEHI and Hudson Institute to improve cancer diagnosis, prevention and treatment.
Scholarship will fund a 3-year PhD candidature to work in the Cancer, Ageing & Vaccine Laboratory (SHBS). Project is a collaboration with WEHI and Hudson Institute to improve cancer diagnosis, prevention and treatment.
- The value of the Scholarship is equivalent to an RMIT full Scholarship
- This Scholarship will be available for 3.5 years.
- The value of the Scholarship is equivalent to an RMIT full Scholarship
- This Scholarship will be available for 3.5 years.
Applicants need to have a background in immunology or cancer biology, preferably cancer immunology and most preferably ovarian cancer. They must have completed a relevant Bachelor’s Degree and Honour’s or Master’s. Due to COVID-19 restrictions, applicants must living in Australia at time of application.
Applicants need to have a background in immunology or cancer biology, preferably cancer immunology and most preferably ovarian cancer. They must have completed a relevant Bachelor’s Degree and Honour’s or Master’s. Due to COVID-19 restrictions, applicants must living in Australia at time of application.
Email Distinguished Professor Magdalena Plebanski (magdalena.plebanski@rmit.edu.au) directly with their statement of interest, cover letter addressing the desirable criteria, CV and academic qualifications.
Also see the HDR How to Apply website .
Email Distinguished Professor Magdalena Plebanski (magdalena.plebanski@rmit.edu.au) directly with their statement of interest, cover letter addressing the desirable criteria, CV and academic qualifications.
Also see the HDR How to Apply website .
Applications are open now.
Applications are open now.
31 December 2023.
31 December 2023.
Three
Three
The Cancer, Ageing and Vaccines Laboratory seeks to understand cancer biology and immune responses and to translate these findings into real-world clinical benefits. As part of this research, the lab runs several clinical trials, such as SOLACE2, which is testing combination chemotherapies for ovarian cancer treatment (Scott et al., 2019, doi.org/10.1111/ajco.13263) and IOCT, which recently identified a key biomarker for diagnosis of ovarian cancer (Kampan et al., 2020, doi: 10.1038/s41598-020-59009-z).
Most recently, is our collaboration with Professor Scott (WEHI) on the Stafford Fox Rare Cancers trial. This trial seeks to understand why people diagnosed with three or more cancers have a much better survival rate than those diagnosed with one or two cancers. The project will study biobanked samples from these "super survivor" individuals to test if they have specific health characteristics, set at just the right level to control or knock out their cancer.
One key goal of these trials is to identify the key functional targets for the immune response and leverage this to initiate development of personalised cancer vaccines. As part of this goal, the PhD candidate could choose to become involved in any number of aspects and Is welcome to discuss ideas and options with Distinguished Professor Magdalena Plebanski.
Across all projects, the PhD Candidate will use techniques such as germline/tumour sequencing data, plasma analysis and work with patients’ immune cells work to identify key functional targets. They may perform epigenetic techniques, DNA sequencing (HLA-typing and WES), transcriptomics and immunoassays such as ELISpots.
Desirable criteria:
- Practical experience and conceptual background in cellular immunology, particularly tumour immunology.
- Practical experience and conceptual background in solid tumour biology, particularly ovarian cancer.
- Interest in, and ability to, work in an interdisciplinary setting including immunologists, cancer biologists, and clinicians.
- Experience in tissue culture.
The Cancer, Ageing and Vaccines Laboratory seeks to understand cancer biology and immune responses and to translate these findings into real-world clinical benefits. As part of this research, the lab runs several clinical trials, such as SOLACE2, which is testing combination chemotherapies for ovarian cancer treatment (Scott et al., 2019, doi.org/10.1111/ajco.13263) and IOCT, which recently identified a key biomarker for diagnosis of ovarian cancer (Kampan et al., 2020, doi: 10.1038/s41598-020-59009-z).
Most recently, is our collaboration with Professor Scott (WEHI) on the Stafford Fox Rare Cancers trial. This trial seeks to understand why people diagnosed with three or more cancers have a much better survival rate than those diagnosed with one or two cancers. The project will study biobanked samples from these "super survivor" individuals to test if they have specific health characteristics, set at just the right level to control or knock out their cancer.
One key goal of these trials is to identify the key functional targets for the immune response and leverage this to initiate development of personalised cancer vaccines. As part of this goal, the PhD candidate could choose to become involved in any number of aspects and Is welcome to discuss ideas and options with Distinguished Professor Magdalena Plebanski.
Across all projects, the PhD Candidate will use techniques such as germline/tumour sequencing data, plasma analysis and work with patients’ immune cells work to identify key functional targets. They may perform epigenetic techniques, DNA sequencing (HLA-typing and WES), transcriptomics and immunoassays such as ELISpots.
Desirable criteria:
- Practical experience and conceptual background in cellular immunology, particularly tumour immunology.
- Practical experience and conceptual background in solid tumour biology, particularly ovarian cancer.
- Interest in, and ability to, work in an interdisciplinary setting including immunologists, cancer biologists, and clinicians.
- Experience in tissue culture.
For further inquiries please contact Distinguished Professor Magdalena Plebanski (magdalena.plebanski@rmit.edu.au).
For further inquiries please contact Distinguished Professor Magdalena Plebanski (magdalena.plebanski@rmit.edu.au).
Similar Positions
-
Bayesian Generative Ai (Ph D Project), Monash University, Australia, about 16 hours ago
For better or for worse, Generative AI is changing our world. A key challenge in Generative AI is many-shot jailbreaking—where a language model, despite being explicitly trained to reject harmful ...
-
Parcel Tracker Passion Project Scholarship, Swinburne University of Technology, Australia, about 7 hours ago
Features FEATURES Scan in Parcels Log inbound parcels and speed up your parcel management process Secure Collections Make sure that every parcel is handed off to the correct person and collect pro...
-
<! Ko If: Is Job Title Visible > Senior Officer, Student Financials & Scholarships <! /Ko > <! Ko If: Is Already Applied Visible ><! /Ko > , Victoria University, Australia, about 9 hours ago
Job Info Job Identification 16086 Job Category Operations Posting Date 07/09/2025, 04:33 AM Locations Footscray Park Apply Before 07/23/2025, 02:59 PM Degree Level Bachelor's Degree Job Schedule F...
-
Ph D Scholarship Movement Metrics For Physical Health, Monash University, Australia, 1 day ago
PhD Scholarship - Movement Metrics for Physical Health Job No.: 682825 Location: Clayton Campus Employment Type: Full-time Duration: 3.5-year fixed-term appointment Remuneration: The successful ap...
-
Ph D Scholarship In Digital Mapping Of Homemade & Diy Cultural Economies In First Nations Communities, Monash University, Australia, 2 days ago
PhD Scholarship in Digital Mapping of Homemade & DIY Cultural Economies in First Nations Communities Job No.: 681214 Location: Clayton campus Employment Type: Full-time Duration: 3.5-year fixed-te...
-
Ph D Scholarship In History, Monash University, Australia, 1 day ago
PhD Scholarship in History Job No.: 678754 Location: Clayton campus Employment Type: Full-time Duration: 3.5-year fixed-term appointment Remuneration: The successful applicant will receive a Resea...